(Adds Exelon, Bayer AG, EQT)
April 30 (Reuters) - The following corporate finance-related stories were reported by media:
* British bank Barclays Plc will next week announce the creation of a bad bank portfolio of assets it deems non-core that it intends to sell or run down as part of a streamlining of its investment bank, a person familiar with the matter said on Tuesday.
* Spanish utility Iberdrola has hired Morgan Stanley to explore the sale of a minority stake in its Spanish distribution business, a source with knowledge of the matter said on Tuesday.
* Sanofi SA is looking to sell a portfolio of mature drugs that could fetch between $7 billion and $8 billion, according to people familiar with the matter, yet another example of drugmakers trying to shed non-core assets and focus on high-growth areas.
* Nuclear power company Exelon Corp agreed to buy utility company Pepco Holdings Inc for more than $5.4 billion in cash, Bloomberg reported, citing people familiar with the transaction.
* Bayer AG is offering to swap its animal health assets for Merck & Co Inc’s consumer healthcare business, people familiar with the matter said on Tuesday, in a move that could give the German drugmaker a leg up in the $14 billion auction of the Merck business.
* Swedish buyout house EQT is planning a stock market listing for hotel operator Scandic, which could be worth more than 1 billion euros ($1.38 billion) including debt, two people familiar with the matter said.
For the deals of the day click on
For the Morning News Call-EMEA newsletter click on (Compiled by Tasim Zahid in Bangalore)